For the quarter ending 2026-03-31, PHIO has $17,412K in assets. $950K in debts. $17,031K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 17,031 | 21,031 | 10,705 | 10,775 |
| Prepaid expenses and other current assets | 371 | 445 | 788 | 519 |
| Total current assets | 17,402 | 21,476 | 11,493 | 11,294 |
| Property, plant and equipment, gross | - | 239 | - | - |
| Less accumulated depreciation and amortization | - | 228 | - | - |
| Property and equipment, net | 10 | 11 | 12 | 7 |
| Total assets | 17,412 | 21,487 | 11,505 | 11,301 |
| Accounts payable | 260 | 435 | 516 | 235 |
| Total current liabilities | - | - | - | 1,206 |
| Accrued expenses | 690 | 905 | 1,150 | 971 |
| Total liabilities | 950 | 1,340 | 1,666 | 1,206 |
| Common stock, 0.0001 par value, 100,000,000 shares authorized 11,617,250 and 11,617,250 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1 | 1 | 1 | - |
| Additional paid-in capital | 175,518 | 175,200 | 162,521 | 160,386 |
| Accumulated deficit | -159,057 | -155,054 | -152,683 | -150,291 |
| Total stockholders' equity | 16,462 | 20,147 | 9,839 | 10,095 |
| Total liabilities and stockholders' equity | 17,412 | 21,487 | 11,505 | 11,301 |
Phio Pharmaceuticals Corp. (PHIO)
Phio Pharmaceuticals Corp. (PHIO)